Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Toumaz Wins Oracle Award

19 Dec 2006 07:02

Nanoscience Inc19 December 2006 Nanoscience Inc. ('The Group') Toumaz Technology Wins Highest Accolade At Oracle Innovation Awards Nanoscience Inc, the specialist niche investor in emerging technologies withstrong commercial propositions from within the growing nanotechnology sector, ispleased to announce that its wholly owned subsidiary Toumaz Technology Limited('Toumaz') has been awarded first prize at the fifth Oracle PartnerNetwork (OPN)Innovation Awards for Europe, the Middle East and Africa. The award from OracleCorporation, the world's largest enterprise software company, recognises theoutstanding innovation of Toumaz's breakthrough SensiumTM platform for wirelessvital signs monitoring. The Oracle PartnerNetwork is a global business networkof more than 17,700 companies who deliver innovative software solutions based onOracle software. The OPN Innovation Awards are designed to reward innovation by OPN members,where initiatives using Oracle's products and technology are applied to createvalue for the customer and generate new business potential. Toumaz was named overall winner in recognition of its groundbreaking SensiumTMsolution, an innovative ultra-low power wireless platform that allows healthcareproviders to remotely monitor multiple vital signs in real-time. Designed towork with a range of physical and bio-chemical sensors, the multi-functionSensium system can be attached to the body with a sticking plaster to delivercontinuous, non-intrusive monitoring and analysis of vital signs includingelectrocardiograms (ECG), blood oxygen and glucose, body temperature, and evenmotion and mobility. This real-time vital signs information is transmittedthrough an Oracle Sensor Edge Server for further processing and filtering and isseamlessly integrated into an Oracle Healthcare Transactional Database, where itis analysed and made available to the appropriate specialists. This end-to-endsystem provides the foundation for a total patient care package, with thepotential to revolutionise health and lifestyle management. Richard Rose, Chairman of Nanoscience, commented: "We are delighted that the innovation and importance of Toumaz's solution hasbeen recognised by Oracle. The OPN Innovation Award is a very significantendorsement for the Sensium platform, and will be a valuable asset in helpingToumaz to achieve further success in the market." Vasu Briquez, Chair of the Oracle Innovation Board in EMEA, commented: "The ability to innovate has always been integral to Oracle's success, and ourpartners also recognize that innovation is one of the keys to maintaining aleadership position. The OPN Innovation Awards provide us with an excellentopportunity to encourage and reward the outstanding initiatives that are beingdeveloped in our partner community." Stein Surlien, Vice President, Alliances & Channels, at Oracle EMEA commented: "We are delighted to reward our partner Toumaz for its truly innovativesolution. We are committed, through the Oracle PartnerNetwork, to providing ourpartners with the support, services and expertise that help them create valuablesolutions and enable their customers to achieve their business goals. Winning anOPN Innovation Award will enhance Toumaz's visibility within the OPN partnercommunity and the wider market. We are proud to be involved with Toumaz and wishthem the greatest success for the future." -Ends - About Toumaz (www.toumaz.com) Toumaz is a developer of advanced RF, analogue and mixed signal semiconductors.The focus of the business is low power devices based on the company'sproprietary AMxTM (Advanced Mixed Signal) technology which addresses the needsof lower power consumption for mobile and wirelessly connected systems. About Oracle Corporation Oracle is the world's largest enterprise software company. For more informationabout Oracle, visit www.oracle.com. About the Oracle PartnerNetwork The Oracle PartnerNetwork is a global business network of more than 17,700companies who deliver innovative software solutions based on Oracle software.Through access to Oracle's premier products, education, technical services,marketing and sales support, the Oracle PartnerNetwork provides partners withthe resources they need to be successful in today's global economy. Oraclepartners are able to offer customers leading-edge solutions backed by Oracle'sposition as the world's largest enterprise software company. Partners who areable to demonstrate superior product knowledge, technical expertise and acommitment to doing business with Oracle qualify for the Oracle CertifiedPartner level. http://oraclepartnernetwork.oracle.com Further information Richard Rose Nanoscience 07836 250 474 Andrew Tan Hansard Group 020 7245 1100 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Oct 20197:30 amRNSSuspension - Frontier Smart Technologies Group
11th Oct 201910:42 amRNSResult of EGM and Suspension of Trading on AIM
8th Oct 20195:30 pmRNSFrontier Smart Technologies Group
3rd Oct 201910:00 amRNSClosure of Romania Operations
11th Sep 20199:30 amRNSBoard Appointments
9th Sep 20196:21 pmRNSRecommended Statutory Merger & AIM Cancellation
6th Sep 20193:20 pmRNSBlock Listing Update
5th Sep 201912:47 pmRNSHolding(s) in Company
3rd Sep 20194:39 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20198:54 amRNSAmendment to Standby Facility
2nd Sep 20195:23 pmRNSHolding(s) in Company
30th Aug 20192:21 pmRNSDirector/PDMR Dealing
30th Aug 20197:00 amRNSHalf-Year Results
29th Aug 20197:00 amRNSResponse to Science Group Statement
28th Aug 20194:23 pmRNSHolding(s) in Company
28th Aug 20198:47 amRNSFrontier Investment Update and Buy-Back
23rd Aug 201912:31 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
23rd Aug 201912:30 pmRNSConfirmation of Refinancing
21st Aug 20197:00 amRNSBoard Transition, Refinancing and Strategy
13th Aug 20197:00 amRNSBoard Change
7th Aug 201911:20 amRNSResponse to announcement by Frontier
7th Aug 20197:00 amRNSTrading & Discussion Update and EGM Requisition
31st Jul 20193:30 pmRNSExercise of Options and Total Voting Rights
30th Jul 20197:00 amRNSBoard Changes
22nd Jul 201910:09 amRNSHolding(s) in Company
22nd Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
19th Jul 20196:09 pmRNSExercise of Options and Total Voting Rights
19th Jul 20197:00 amRNSHolding(s) in Company
19th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
18th Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
17th Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
16th Jul 20197:00 amRNSHolding(s) in Company
16th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
15th Jul 20198:02 amRNSHolding(s) in Company
15th Jul 20197:00 amRNSFurther Response to Science Group Offer
15th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
12th Jul 20194:07 pmRNSInvestment in Frontier Smart Technologies Group
12th Jul 20193:00 pmRNSFurther Response to Science Group Offer
12th Jul 20197:00 amRNSHolding(s) in Company
12th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
8th Jul 20197:00 amRNSHolding(s) in Company
8th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
5th Jul 20197:00 amRNSFurther Response to Offer & update on discussions
2nd Jul 201912:20 pmRNSPublication of Offer Document
1st Jul 20199:01 amRNSResponse to Science Group Statement
1st Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
27th Jun 20194:10 pmRNSExercise of Options and Total Voting Rights
14th Jun 201911:40 amRNSInvestment in Frontier Smart Technologies Grp Ltd
14th Jun 20198:31 amRNSResponse to Science Group's announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.